{"version":"1.0","type":"link","title":"A novel synergistic drug combination of a mitogen-activated extracellular signal-regulated kinase inhibitor with [Lu]Lu-rhPSMA-10.1 for prostate cancer treatment: Results of a preclinical evaluation.","author_name":"Foxton C 외","author_url":"https://prs-insight.online/author/Foxton%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/137760","thumbnail_width":1200,"thumbnail_height":630}